Heska (HSKA:NASDAQ) Investor Relations Material

Overview

Heska Corporation, a leading manufacturer and vendor of diagnostic and specialty products and solutions for veterinary practitioners, has a global presence in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers an extensive range of products, including veterinary chemistry analyzers for blood chemistry and electrolyte analysis, hematology analyzers, blood gas and electrolyte analyzers, immunodiagnostic analyzers, veterinary analyzers, IV infusion pumps, digital radiography hardware and mobile digital radiography products, ultrasound systems, and various other point-of-care products. Additionally, the company provides bovine vaccines, biological and pharmaceutical products to other animal health companies, and turnkey services such as research, licensing, production, labeling, and packaging. Heska corporation facilitates its sales through a telephone sales force and third-party distributors, as well as trade shows, print advertising, and other distribution partnerships. Based in Loveland, Colorado, the company was established in 1988 under the name Paravax, Inc. and later changed its name to Heska Corporation in 1995.

Frequently Asked Questions

What is Heska's ticker?

Heska's ticker is HSKA

What exchange is Heska traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Heska's headquarters?

They are based in Loveland, Colorado

How many employees does Heska have?

There are 201-500 employees working at Heska

What is Heska's website?

It is heska.com

What type of sector is Heska?

Heska is in the Healthcare sector

What type of industry is Heska?

Heska is in the Biotechnology industry

Who are Heska's peers and competitors?

The following five companies are Heska's industry peers:

- C4X Discovery

- Syndax Pharmaceuticals

- Akcea Therapeutics, Inc.

- Pieris Pharmaceuticals

- Cara Therapeutics